Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Bayer Expects HealthCare Sales Of About EUR 20 Bln In 2014 - Quick Facts

German conglomerate Bayer AG (BAYRY.PK,BAYZF.PK) on Wednesday said it sees good perspectives for its businesses in the medium term.

At the "Meet Management" investor conference on Wednesday in Leverkusen, CEO Marijn Dekkers said, "In the life science areas - HealthCare and CropScience - we anticipate further increases in sales and margins through 2014."

The company expects sales of Bayer HealthCare to reach approximately 20 billion euros in 2014, while Bayer CropScience aims to raise sales to more than 8 billion euros.

Bayer added that its MaterialScience segment intends to further strengthen its leading position in the market and plans to achieve volume gains in excess of the rate of global GDP growth.

Dekkers added that the main reason for the optimistic outlook for HealthCare subgroup is its well-stocked development pipeline in Pharmaceuticals. "We believe four of our medicines in late-stage development have blockbuster potential. That means each of these products could achieve peak annual sales of EUR 1 billion or more," he added.

The company added that it aims to successfully commercialize the late-stage pharmaceutical pipeline and take advantage of business opportunities in the emerging markets.

Register
To receive FREE breaking news email alerts for Bayer AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.